Intra-Cellular Therapies, Inc. Quarterly Operating Margin in % from Q4 2013 to Q4 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2013 to Q4 2022.
  • Intra-Cellular Therapies, Inc. Operating Margin for the quarter ending December 31, 2022 was -105 %, a 69.1% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Operating Margin for 2017 was -41.8K %, a 17% decline from 2016.
  • Intra-Cellular Therapies, Inc. annual Operating Margin for 2016 was -35.8K %, a 69.1% increase from 2015.
  • Intra-Cellular Therapies, Inc. annual Operating Margin for 2015 was -116K %, a 2058% decline from 2014.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -105 +236 +69.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -161 +209 +56.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -234 +196 +45.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -296 +329 +52.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -341 +673 +66.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -370 +1.66K +81.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -430 Apr 1, 2021 Jun 30, 2021
Q1 2021 -626 Jan 1, 2021 Mar 31, 2021
Q4 2020 -1.01K Oct 1, 2020 Dec 31, 2020
Q3 2020 -2.03K Jul 1, 2020 Sep 30, 2020
Q4 2017 -41.8K Oct 1, 2017 Dec 31, 2017
Q3 2017 -29K Jul 1, 2017 Sep 30, 2017
Q2 2017 -33.5K Apr 1, 2017 Jun 30, 2017
Q1 2017 -27.6K Jan 1, 2017 Mar 31, 2017
Q2 2015 -26.3K -25.1K -2146% Apr 1, 2015 Jun 30, 2015
Q1 2015 -11.8K -10.7K -972% Jan 1, 2015 Mar 31, 2015
Q4 2014 -5.37K -4.41K -459% Oct 1, 2014 Dec 31, 2014
Q3 2014 -1.77K Jul 1, 2014 Sep 30, 2014
Q2 2014 -1.17K Apr 1, 2014 Jun 30, 2014
Q1 2014 -1.1K Jan 1, 2014 Mar 31, 2014
Q4 2013 -960 Oct 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.